Latest Quarterly Results
Quarter Ended October 31, 2020
(20.2%)
Comparable sales decline of (21.0%) on an owned basis; comparable sales decline of (20.2%) on an owned plus licensed basis.
$4.0B
Net Sales
($0.19)
Diluted EPS of ($0.29); ($0.19) per share excluding restructuring, impairment, settlement charges and other costs.
Source:
For complete information regarding our financials, see our periodic filings.
Latest Financial Results
Q3 2020
Quarter Ended Oct 31, 2020